The report identifies and analyses the key companies shaping and driving the global Peripheral Artery Disease market

PUNE , MAHARASHTRA, INDIA, September 19, 2016 /EINPresswire.com/ -- Peripheral Artery Disease

Description

GlobalData has released its pharma report, “Peripheral Artery Disease - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Peripheral Artery Disease Market. The report identifies and analyses the key companies shaping and driving the global Peripheral Artery Disease market. The report provides insight into the competitive Peripheral Artery Disease landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Report Detail’s@ https://www.wiseguyreports.com/reports/643853-peripheral-artery-disease-current-and-future-players


Scope

- Investigation of current and future market competition for Peripheral Artery Disease
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Peripheral Artery Disease sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Peripheral Artery Disease market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Peripheral Artery Disease market landscape? Identify, understand and capitalize

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/643853-peripheral-artery-disease-current-and-future-players



Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Catalyst 5
2.2 Related Reports 6
2.3 Upcoming Related Reports 6
3 Market Outlook 7
3.1 Global Markets 7
3.1.1 Forecast 7
3.1.2 Drivers and Barriers - Global Issues 12
4 Current and Future Players 17
4.1 Overview and Trends in Corporate Strategy 17
4.2 Company Profiles 21
4.2.1 Bayer 21
4.2.2 Janssen (Johnson & Johnson) 23
4.2.3 AstraZeneca 25
4.2.4 Merck & Co. 28
4.2.5 Sanofi 29
4.2.6 Pfizer 31
4.2.7 Bristol-Myers Squibb 32
4.2.8 Otsuka Holdings 33
5 Appendix 35
5.1 Bibliography 35
5.2 Abbreviations 63
5.3 Methodology 68
5.4 Forecasting Methodology 68
5.4.1 Diagnosed PAD Patients 68
5.4.2 Percent Drug-Treated Patients 69
5.4.3 Drugs Included in Each Therapeutic Class 69
5.4.4 Launch and Patent Expiry Dates 69
5.4.5 General Pricing Assumptions 70
5.4.6 Individual Drug Assumptions 71
5.4.7 Generic Erosion 76
5.4.8 Pricing of Pipeline Agents 76
5.5 Physicians and Specialists Included in this Study 77
5.6 About the Authors 81
5.6.1 Analyst 81
5.6.2 Therapy Area Director 81
5.6.3 Epidemiologist 82
5.6.4 Global Head of Healthcare 82
5.6.5 Global Director of Therapy Analysis and Epidemiology 83
5.7 About GlobalData 84
5.8 Disclaimer 84

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=643853

Continued...

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here